Twist Bioscience Corp’s recent filing unveils that its Director JOHANNESSEN JAN acquired Company’s shares for reported $0.17 million on Nov 18 ’25. In the deal valued at $24.77 per share,7,044 shares were bought.
Then, Cho Dennis sold 1,019 shares, generating $32,689 in total proceeds. Upon selling the shares at $32.08, the insider now owns 120,694 shares.
Before that, Finn Patrick John sold 2,755 shares. Twist Bioscience Corp shares valued at $88,379 were divested by the President and COO at a price of $32.08 per share. As a result of the transaction, Finn Patrick John now holds 265,919 shares, worth roughly $6.91 million.
Stephens initiated its Twist Bioscience Corp [TWST] rating to an Overweight in a research note published on November 04, 2025; the price target was $41. A number of analysts have revised their coverage, including Wolfe Research’s analysts, who began to cover the stock in mid December with a ‘”an Outperform”‘ rating. Guggenheim began covering TWST with “Buy” recommendation on June 04, 2024. Goldman revised its rating on January 17, 2024. It rated TWST as “a Buy” which previously was an “a Neutral”.
Price Performance Review of TWST
On Tuesday, Twist Bioscience Corp [NASDAQ:TWST] saw its stock fall -1.74% to $26.0. Over the last five days, the stock has lost -16.99%. Twist Bioscience Corp shares have fallen nearly -33.26% since the year began. Nevertheless, the stocks have fallen -44.05% over the past one year. While a 52-week high of $55.33 was reached on 01/24/25, a 52-week low of $23.30 was recorded on 11/14/25.
Levels Of Support And Resistance For TWST Stock
The 24-hour chart illustrates a support level at 24.69, which if violated will result in even more drops to 23.37. On the upside, there is a resistance level at 27.03. A further resistance level may holdings at 28.06.
How much short interest is there in Twist Bioscience Corp?
A steep rise in short interest was recorded in Twist Bioscience Corp stocks on 2025-10-31, dropping by -2.43 million shares to a total of 10.55 million shares. Yahoo Finance data shows the prior-month short interest on 2025-09-30 was 12.98 million shares. There was a decline of -23.08%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on September 27, 2023 when Berenberg began covering the stock and recommended ‘”a Buy”‘ rating along with a $27 price target.
